But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks ...

But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks ...

Globus Medical, Inc.’s GMED growth in the third quarter can be attributed to the robust prospect in the musculoskeletal space. The company’s merger with NuVasive is expected to generate ...

But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with ... across 51 counties worldwide. GMED is a #3 (Hold) on the Zacks ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $100.00. The company’s shares closed last ...

In a report released today, David Saxon from Needham maintained a Hold rating on Globus Medical (GMED – Research Report). The company’s shares opened today at $92.41. Leverage the power of ...

The company currently has its sales operations distributed across 51 counties worldwide. GMED boasts a Growth Style Score of A and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating.

The company currently has its sales operations distributed across 51 counties worldwide. GMED is a Zacks Rank #3 (Hold) stock, with a Growth Style Score of A and VGM Score of A. Earnings are expected ...